Canaccord analyst Kyle Mikson raised the firm’s price target on Exact Sciences to $120 from $115 and keeps a Buy rating on the shares. The firm said their solid results were driven by continued Cologuard volume growth, with revenue from this product increasing over 30% year-over-year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EXAS: